Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1052 of 5804
-
New narcolepsy pill aims to banish daytime drowsiness
Symptom relief Recruiting nowThe purpose of this study is to measure decreases in daytime sleepiness, and disease symptoms in participants with Narcolepsy Type 2 (NT2) when taking ALKS 2680 tablets compared with placebo tablets.
Phase: PHASE3 • Sponsor: Alkermes, Inc. • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
One-Week radiation for breast cancer lymph nodes could be as effective as three weeks
Disease control Recruiting nowFor patients with breast cancer, regional nodal irradiation (RNI) can significantly reduce the risks of recurrence and mortality. Moderate hypofractionated regimens (40 to 42.5 Gy in 15 to 16 fractions over 3 weeks) is the established standard of care for RNI. Nevertheless, for t…
Phase: NA • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New drug aims to cut transfusions for MDS patients
Disease control Recruiting nowThe main aim of the study is to evaluate how TAK-226 improves symptoms of transfusion-dependent anemia in Japanese patients with lower-risk myelodysplastic syndromes. The study consists of Screening Period (up to 6 weeks), Treatment Period, Safety Follow-Up Period (8 weeks), and…
Phase: PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New hope for advanced breast cancer: drug combo trial launches
Disease control Recruiting nowThe study is a Phase 1b/2, multi-center, open-label, dose escalation trial evaluating the safety and preliminary efficacy of sapanisertib and serabelisib (PIKTOR) with fulvestrant and/or other anticancer therapies in participants with HR+/HER2- advanced/metastatic breast cancer.
Phase: PHASE1, PHASE2 • Sponsor: Faeth Therapeutics • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Sleep sounds may sharpen minds in Parkinson's
Symptom relief Recruiting nowPeople with Parkinson's disease are at higher risk of cognitive decline, and current treatments cannot fully prevent this. This study explores non-drug ways to support brain function. Intervention: Participants will complete a 5-week cognitive training program at home ("brain fi…
Phase: NA • Sponsor: University of Zurich • Aim: Symptom relief
Last updated Jun 27, 2026 12:26 UTC
-
New DNA scanner could solve dystonia mystery for thousands
Diagnosis Recruiting nowDystonia is a motor disorder caused by involuntary, intermittent, or sustained muscle contractions, leading to abnormal movements or postures. It can affect any body region and often results in significant functional disability and healthcare burden. Although its familial nature …
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Diagnosis
Last updated Jun 27, 2026 12:35 UTC
-
New drug aims to shrink hard-to-treat tumors
Disease control Recruiting nowThis is a first in human (FIH), Phase 1 dose escalation and expansion study in select solid tumors. This study includes 2 parts: a Dose Escalation and Backfill portion (Part A) and a Dose Expansion portion (Part B).
Phase: PHASE1 • Sponsor: NEOK Bio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Spinal implant aims to restore leg movement in groundbreaking 2-person trial
Disease control ENROLLING_BY_INVITATIONThis proof-of-concept case series will prospectively use magnetic resonance imaging (MRI) evidence of spared spinal cord neural fibers to guide the selection of 2 research participants to receive a surgically implanted epidural stimulator with the goal of restoring voluntary move…
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Could an ADHD drug help curb cocaine addiction?
Disease control Recruiting nowIn The Netherlands, each year, about 15 thousand people come into treatment because of problems with cocaine use. There is no approved medication for treatment of cocaine addiction and the psychosocial treatment patients receive is not successful for everyone; many return to trea…
Phase: PHASE2 • Sponsor: Parnassia Addiction Research Centre • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New eye drug AVT29 takes on eylea HD in DME trial
Disease control Recruiting nowThis is a Randomized, Double-masked, Parallel-group, Multicenter Clinical Study to Evaluate the Efficacy and Safety of AVT29 Compared with Eylea HD in Participants with Diabetic Macular Edema.
Phase: PHASE3 • Sponsor: Alvotech Swiss AG • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Can a phone app help catch Post-C-Section infections in rural rwanda?
Disease control ENROLLING_BY_INVITATIONCesarean sections (c-sections) are one of the most common surgical procedures done globally. However, there has been an increase in the number of c-section related complications. Women who deliver via c-section are nearly twice as likely to experience a complication (not includin…
Phase: NA • Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Balloon battle: could a Drug-Coated balloon replace stents in tiny heart vessels?
Disease control Recruiting nowThe main objective of the SPARX trial is to compare paclitaxel-coated balloons to with contemporary DES in complex and small coronary artery lesions in patients with NSTEACS or CCS; the co-primary objective is to compare two different paclitaxel-coated balloons, Protégé and Agent…
Phase: NA • Sponsor: Translumina GmbH • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can brain zaps and cash rewards break Cocaine's grip?
Disease control Recruiting nowThe purpose of this study is to evaluate the effects of Contingency Management (CM)+transcranial magnetic stimulation (TMS) on treatment outcomes in individuals who are initial non-responders and to evaluate the effects of CM+TMS on putative mechanisms of change
Phase: NA • Sponsor: The University of Texas Health Science Center, Houston • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New hope for kids with rare swelling disorder as drug trial begins
Disease control Recruiting nowThe purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of donidalorsen in pediatric participants with hereditary angioedema (HAE) Type I (HAE-1) or Type II (HAE-2).
Phase: PHASE3 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Brain zaps for Alzheimer's: new study targets gut bugs to boost memory
Disease control Not yet recruitingWhat is this study about? This study focuses on Alzheimer's Disease (AD), a common neurodegenerative disease that affects memory, thinking, and daily life. We aim to explore whether a non-invasive treatment called Repetitive Transcranial Magnetic Stimulation (rTMS) can improve AD…
Phase: NA • Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New vaccine combo aims to rally immune system against tough cancers
Disease control Recruiting nowThis is an open-label, non-randomized, single-center, dose-escalation Phase 1 trial using a heterologous prime-boost strategy of vaccination with Ad5.F35-hGUCY2C-PADRE and recombinant Listeria monocytogenes (Lm-GUCY2C) vaccines in patients with advanced solid tumors including col…
Phase: PHASE1 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Laser therapy offers hope for breast cancer survivors suffering from vaginal dryness
Symptom relief Recruiting nowThis phase III trial tests whether vaginal fractional CO2 laser therapy works in treating vaginal dryness in breast cancer survivors. Vaginal dryness can be commonly experienced with normal aging, with menopause, or come about from medications used to treat breast cancer such as …
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
New weekly shot could help shed pounds in obesity trial
Disease control Recruiting nowThe purpose of this clinical study is to find out if NNC0487-0111 is safe and effective for treating people who have excess body weight. There are 2 study treatments in this study taken as injections under the skin once a week. Participants will either get NNC0487-0111 (the treat…
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New drug combo after transplant aims to stop leukemia relapse and graft-versus-host disease
Disease control Recruiting nowThis phase I trial studies the side effects and best dose of ruxolitinib (Rux) therapy alone (monotherapy) followed by Rux plus azacitidine (AZA) maintenance therapy and to see how well it works in treating patients with acute myeloid leukemia (AML) who are undergoing reduced int…
Phase: PHASE1 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Could a zapping helmet ease Parkinson's symptoms?
Symptom relief Recruiting nowThis clinical trial will evaluate the efficacy of accelerated Temporal Interference Stimulation (TIS) as a therapeutic intervention for individuals diagnosed with Parkinson's disease or secondary Parkinson's syndrome. Accelerated TIS will be delivered targeting the bilateral subt…
Phase: NA • Sponsor: Ke Dong, MD • Aim: Symptom relief
Last updated Jul 23, 2026 00:00 UTC